2019-nCoV Antigen Rapid Test Kit (Colloidal gold Assay)
Specimen Type: Siliva
Time to result: 15 minutes quick test
Storage: 18 months (room temperature)
Package: 25 Tests/Box ( 25 test cassettes + 25 Antigen extraction tubes + 25 Saliva sampling cups+ 25 Sampling droppers + 1 bottle Antigen extract R1 buffer+ 1 Test tube stand + 1 manual)
Relative Sensitivity: 90.3%.
New products will be launced in next 2 weeks, please mantain your attention!
2019-nCoV Antigen Rapid Test Kit (Colloidal gold Assay)
Specimen Type: Nasopharyngeal Swab
Time to result: 15 minutes quick test
Storage: 18 months (room temperature)
Package: 25 Tests/Box (25 pcs Nasopharyngeal swab + 25 test cassettes + 1 bottle Antigen extraction tube + 1 bottle Antigen extract R1)
Relative Sensitivity: >85%
Short test time: Within 15 Minutes
Accuracy: More than 90%
Easy operation: Throat/Nose swab, Saliva sample.
One-step solution - Lower cost with high efficiency
Components:
A 25 test cassettes
B 25 Antigen extraction tubes
C 1 bottle antigen extract R1
D 1 Test tube stand
E 25pcs Saliva Sample cups
F 25pcs disposable droppers
G 1 manual
Application:
A Suspected case test in epidemic area
B Early test of fever clinic and CDC
C Screening of primary medical institutions
D Inspection of floating population in public areas
Product Information:
Product Name : 2019-nCoV Antigen Rapid Test Kit
Methodology : Colloidal Gold Assay
Size: 25 Tests/box
Storage and Validity: Stored at 2-30 within 18 months
Specimen: Nasopharyngeal Saliva
Read the results in 15 minutes. A strong positive results may show within 15 minute.
But the negative result must be reported after 15 minutes. And the results after 20 minutes are not valid anymore.
1697 Rapid Test Kits Suppliers
Short on time? Let Rapid Test Kits sellers contact you.
Self-test received notified body approved CE Marking on April 1, 2021
A home test for the rapid qualitative detection of SARS-Cov-2 virus antigen in
anterior nasal swabs from individuals with or without symptoms or other
epidemiological reasons to suspect COVID-19
Performance Characterisitics
Sample tyep: nasal swab Time to result: 15-20 minutes
Sensitivity: 97.70% Specificity: 99.84% Accuracy:98.97%
Layperson study statistics
99.84% of non-professionals carried out the test without requiring assistance
99.82% of different types of results were interpreted correctly.
Specifications
1 Test/kit
Catalog No.: 1N40C5-2
Kit components:
1 Rapid SARS-CoV-2
Antigen Test Card (sealed foil pouch)
1 sterilized swab
1 extraction tube
1 sample extraction buffer
IFU
Tube holder on back of box
The lab indicated that the recombinant protein of Indian mutant (B.1.617.2),
A.23.1(Unit Kingdom), AT.1 (Russia), B.1.1.7(Unit Kingdom), B.1.351 (South Africa),
B.1.616 (France), B.1.621 (Colombia), C.36 (Egypt), C.37 (Peru), P.1 (Japan/Brazil),
P.2 (Brazil) can be detected by Jinwofu SARS-CoV-2 Antigen Test Kit.
For the newly descovered mutant Omicron(B.1.1.529), we performed sequence
alignment analysis on its mutation sites, and found that all the mutation sites were
outside the epitope region recognized by the monoclonal antibody selected by our company.
By bioinformatics analysis, Jinwofu SARS-CoV-2 Antigen Test Kit can also effectively detect
mutant Omicron(B.1.1529)
380 000 pcs single package SELF-TEST 1pcs KIT Goldsite CE1434
LAIENTEST NASAL
Price start from 1.79
IFU inside EN / DE / PL
BOX PL / EN / DE
Optional PDF IFU FR / IT / ES / DA
Self-test received notified body approved CE marking on April 1, 2021
A home test for the rapid qualitative detection of SARS-CoV-2 virus antigen in anterior nasal swabs within 7 days of symptom onset
Performance Characteristics
Sample type: nasal swab
Time to result: 15-20 min
Sensitivity: 96.77%
Specificity: 99.20%
Accuracy: 98.72%
Layperson study statistics:
o 99.10% of non-professionals carried out the test without requiring assistance
o 97.87% of different types of results were interpreted correctly
Our Panodyne Sars-CoV-2 Antigen rapid swab test kits offers a quick and efficient solution for the early detection of COVID-19 infection within both symptomatic and asymptomatic individuals. Uses a specially designed swab to take samples from either the nasal cavity or tonsils to reveal if a person is infected or not. Suitable for mass testing and for screening workforce in business settings.
Description
Foot-and-mouth disease virus (FMDV) causes an acute vesicular disease of cloven-hoofed animals and continues to be a threat to livestock worldwide with outbreaks causing severe economic losses.
RIDX FMDV 3Diff/PAN Ag Combo Test Kit is a lateral flow chromatographic immunoassay for the qualitative detections of all 7 serotypes antigens of FMDV in bovine or porcine samples.
3Diff Ag Test: FMDV 3Diff detects FMDV Asia1, type A, and type O antigens. Three test lines (AS, A, O) and the control (C) line on the surface of the device.
PAN Ag Test: FMDV PAN detects all 7 serotypes (type O, type A, type C, Asia1, SAT1, SAT2, and SAT3) of FMDV antigens. The test line (PAN) and the control (C) line on the surface of the device.
If the FMDV antigens exist in the sample, that bind to the gold-conjugated FMDV antibodies. The complexes move through the membrane by capillary force and respond to the FMDV antibodies on the test line, resulting in a red line. The control line indicates that the test is performed correctly.
The highly selective and sensitive four monoclonal antibodies to FMDV are used as capture and detector in RIDX�® FMDV 3Diff/PAN Ag Combo Test Kit. These antibodies are capable of detecting FMDV antigens in bovine and porcine samples with high accuracy.
Specimen
Bovine or porcine saliva, tissue or vesicular fluid around lip, tongue, gums, nose, or hoof
Features
Clinical Sensitivity
1. Type O 88.2% (n=60/68) vs. PCR
2. Type A 100% (n=70), Asia1 100% (n=62), SAT1 100% (n=20), SAT2 100% (n=20), SAT3 100% (n=20), C 100% (n=20), in spiking samples with virus (titer: 1.0x105 TCID50/ml or higher)
Clinical Specificity
1. Type O, type A and PAN: Bovine 100% (n=92), Swine 100% (n=400)
2. Type Asia1: Bovine 100% (n=92), Swine 99.5% (n=398/400) Differential diagnosis of 3 different serotypes (O, A, Asia1) of FMDV
Concurrent diagnosis both of viral common antigens (all 7 serotypes) and serotype-specific antigens (O, A, Asia1)
